scPharmaceuticals Inc. #SCPH shares closed Thursday down 30% to $9.94 following news FDA identified certain deficiencies with it’s NDA for Furoscix Infusor, furosemide. Unless the issue is very, very quick-resolving, this date is probably going to get changed by 2-3 months.